scispace - formally typeset
J

Johan C. de Jongste

Researcher at Boston Children's Hospital

Publications -  62
Citations -  2933

Johan C. de Jongste is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Asthma & Population. The author has an hindex of 25, co-authored 62 publications receiving 2570 citations. Previous affiliations of Johan C. de Jongste include Erasmus University Rotterdam.

Papers
More filters
Journal ArticleDOI

Measurements of exhaled nitric oxide in healthy subjects age 4 to 17 years

TL;DR: Fractional exhaled nitric oxide in healthy children is below 15 to 25 ppb depending on age and self-reported atopy, and higher FE NO was seen in children with self- reported rhinitis/conjunctivitis or hay fever.
Journal ArticleDOI

Medication adherence and the risk of severe asthma exacerbations: a systematic review

TL;DR: High-quality studies indicated that better adherence is associated with fewer severe asthma exacerbations in high- quality studies, and future studies should use standardised methodology to assess adherence and exacerbations, and should consider inhaler competence.
Journal ArticleDOI

Comparison of childhood wheezing phenotypes in 2 birth cohorts: ALSPAC and PIAMA

TL;DR: The authors used longitudinal latent class analysis to identify phenotypes on the basis of repeated reports of wheezing from 0 to 8 years in 5760 children from the Avon Longitudinal Study of Parents And Children (ALSPAC) and 2810 children from PIAMA study.
Journal ArticleDOI

Tracheomalacia and Bronchomalacia in Children: Incidence and Patient Characteristics

TL;DR: Primary airway malacia is not rare in the general population, with an estimated incidence of at least 1 in 2,100 children, and bronchoscopy is recommended in patients with impaired exercise tolerance, recurrent lower airways infection, and therapy-resistant, irreversible, and/or atypical asthma to rule out airwaymalacia.
Journal ArticleDOI

The acquisition of tolerance toward cow's milk through probiotic supplementation: A randomized, controlled trial

TL;DR: Supplementation of CRL431 and Bb-12 to extensively hydrolyzed formula does not accelerate CM tolerance in infants with CMA and the cumulative percentage of tolerance to CM at 6 and 12 months was similar in both groups.